References
- Aiello RJ, Bourassa PA, Lindsey S, et al. (2002). Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol 22:443–9
- Birke FW, Meade CJ, Anderskewitz R, et al. (2001). In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist. J Pharmacol Exp Ther 297:458–66
- Di Gennaro A, Haeggstrom JZ. (2013). Targeting leukotriene B in inflammation. Expert Opin Ther Targets 8:79–93
- Goodnow RA Jr, Hicks A, Sidduri A, et al. (2010). Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1. J Med Chem 53:3502–16
- Griffiths RJ, Pettipher ER, Koch K, et al. (1995). Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA 92:517–21
- Guerrero AT, Verri WA Jr, Cunha TM, et al. (2008). Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2. J Leukoc Biol 83:122–30
- Huang Q, Riviere JE. (2014). The application of allometric scaling principles to predict pharmacokinetic parameters across species. Expert Opin Drug Metab Toxicol 10:1241–53
- Liston TE, Conklyn MJ, Houser J, et al. (1998). Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration. Br J Clin Pharmacol 45:115–21
- Mahmood I, Balian JD. (1996). Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica 26:887–95
- Rahavendran SV, Vekich S, Skor H, et al. (2012). Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS. Bioanalysis 4:1077–95
- Showell HJ, Pettipher ER, Cheng JB, et al. (1995). The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. J Pharmacol Exp Ther 273:176–84
- Singh RK, Tandon R, Dastidar SG, Ray A. (2013). A review on leukotrienes and their receptors with reference to asthma. J Asthma: Off J Assoc Care Asthma 50:922–31
- Souza DG, Pinho V, Cassali GD, et al. (2002). Effect of a BLT receptor antagonist in a model of severe ischemia and reperfusion injury in the rat. Eur J Pharmacol 440:61–9
- Yokomizo T. (2011). Leukotriene B4 receptors: novel roles in immunological regulations. Adv Enzyme Regul 51:59–64